AstraZeneca’s prescription medication Onglyza, used to treat type-2 diabetes, may cause an increase in certain cardiovascular events and could even result in heart failure.
Onglyza is used to control high blood sugar in patients with type-2 diabetes. However, the Food and Drug Administration (FDA) has recently begun investigating concerns that Onglyza and certain other diabetes medications may be one of the causes of heart failure.
What is Onglyza?
Onglyza is the brand name for a type-2 diabetes medication that regulates the levels of insulin a patient’s body produces. Onglyza and other drugs with the same active ingredient, saxagliptin, are popular medications because they can effectively help control blood sugar without encouraging weight gain as other diabetes medications often can.
AstraZeneca received FDA approval to bring the drug to market in 2009. While the drug has been shown to improve blood glucose levels in patients, it has not been without controversy. Some injured patients have alleged in Onglyza lawsuits that AstraZeneca may have withheld important data regarding the potential link between Onglyza and heart failure.
Onglyza and Heart Failure Risks
These risks are based on a 2013 study published in the New England Journal of Medicine (NEJM), which found that, compared to a placebo, saxagliptin resulted in a 27 percent increase in the rate of patient hospitalization for heart failure. The study also found that saxagliptin users had increased risk for all-cause mortality.
Based on the NEJM study findings, the FDA convened a meeting of its Endocrinologic and Metabolic Drugs Advisory Committee in April 2015 to assess the risk of saxagliptin and heart failure. 14 of 15 committee panelists voted for an updated Onglyza label that warns about the increased risk of saxagliptin and heart failure when using Onglyza. One panel member voted to withdraw Onglyza from the U.S. market.
What is Heart Failure?
Heart failure occurs when the heart is weakened and no longer pumps blood as effectively as it should. This condition can prevent the different organ systems of the body from receiving the oxygen and nutrients that they need. Heart failure is typically the result of adverse health conditions, such as coronary artery disease or high blood pressure, that can gradually leave your heart muscles weakened.
While the exact causes of heart failure in diabetic patients vary, signs and symptoms indicative of diabetes and heart failure may include shortness of breath (dyspnea), fatigue, weakness, and swelling in the legs, ankles, or feet. This can make daily activities extremely difficult — especially climbing stairs, carrying groceries, or walking.
Researchers have found that patients who have been prescribed Onglyza or similar DPP-4 inhibitor medications are at an increased risk of heart failure.
Diabetes and Heart Failure Lawsuits
Many patients have come forward to file heart failure lawsuits after experiencing complications from Onglyza and other similar drugs such as Kombiglyze XR. These claims allege that the pharmaceutical manufacturers failed to inform doctors and patients alike of the increased risk of these complications.
If you were prescribed Onglyza for the treatment of diabetes and experienced severe side effects such as cardiovascular disease or heart failure, you may be entitled to compensation for the cost of medical care, pain and suffering and any additional financial losses you may be forced to incur in the present or the future.
In general, Onglyza lawsuits are filed individually by each plaintiff and are not class actions.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual Onglyza lawsuit or Ongylyza class action lawsuit is best for you. Hurry — statutes of limitations may apply.
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2016 Top Class Actions® LLC
Various Trademarks held by their respective owners
Get Help – It’s Free
Join a Free Onglyza Lawsuit Investigation
If you or a loved one were injured from Onglyza side effects such as heart failure, thyroid cancer or pancreatic cancer, you may have a legal claim. See if you qualify to pursue compensation and join a free Onglyza lawsuit investigation by submitting your information for a free case evaluation.
An attorney will contact you if you qualify to discuss the details of your potential case.
- First Name*
- Last Name*
- Street Address*
- Apt. #
- City*
- State*
AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyomingArmed Forces AmericasArmed Forces EuropeArmed Forces Pacific
- Zip Code*
- Phone*
- Email*
- Which diabetes drug did you/your loved one take?*
- Onglyza
- Kombiglyze XR
- Other (please describe in additional details box below)
- What year did you/your loved one start taking this medication?*
- Which of the following problems did you/your loved one experience after taking this medication?*
-
Heart Failure
-
Heart Attack
-
Pancreatic Cancer
-
Thyroid Cancer
-
Death
-
Other (please describe in the additional details box below)
-
- What year were you/your loved one diagnosed with one or more of these problems?*
- ¿Necesita un orador español?
- Yes
- No
- Please enter any additional details you would like the staff reviewing your submission to know.*
- I understand and agree that submitting this form does not create an attorney-client relationship and that the information I submit is not confidential or privileged and may be shared.*
-
Yes
-
-
if(typeof gf_global == ‘undefined’) var gf_global = {“gf_currency_config”:{“name”:”U.S. Dollar”,”symbol_left”:”$”,”symbol_right”:””,”symbol_padding”:””,”thousand_separator”:”,”,”decimal_separator”:”.”,”decimals”:2},”base_url”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms”,”number_formats”:[],”spinnerUrl”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms\/images\/spinner.gif”};jQuery(document).bind(‘gform_post_render’, function(event, formId, currentPage){if(formId == 141) {gformInitChosenFields(‘#input_141_5′,’No results matched’);if(!/(android)/i.test(navigator.userAgent)){jQuery(‘#input_141_7’).mask(‘(999) 999-9999’).bind(‘keypress’, function(e){if(e.which == 13){jQuery(this).blur();} } );}} } );jQuery(document).bind(‘gform_post_conditional_logic’, function(event, formId, fields, isInit){gformInitChosenFields(‘#input_141_5′,’No results matched’);} ); jQuery(document).ready(function(){jQuery(document).trigger(‘gform_post_render’, [141, 1]) } );
The post Onglyza Use Draws Concern Over Possible Heart Failure Risk appeared first on Top Class Actions.
No comments:
Post a Comment